Recent advances in sepsis and septic shock

Symposium on Advances in Therapy
  • 368 Downloads

Abstract

Sepsis remains a common problem in all age groups. Recently surviving sepsis campaign has taken up a worldwide initiative by publishing international guidelines 2008 with a hope to disseminate information regarding management of sepsis for all age groups. This article presents a review of recent advances as they apply to pediatric age group supported by the available evidence with reference to standard definitions of pediatric sepsis and septic shock and management in the emergency room and pediatric intensive care unit.

Key words

Sepsis Septic shock Shock Pediatric Guidelines Surviving spesis compaign 

References

  1. 1.
    Bone RC, Balk RA, Cerra FB. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis THE ACCP/SCCM consensus conference committee. Chest 1992; 101: 1644–1655.PubMedCrossRefGoogle Scholar
  2. 2.
    Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Dellinger RP, Carlet JM, Masur H. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858–873.PubMedCrossRefGoogle Scholar
  4. 4.
    Dellinger RP, Levy MM, Carlet JM et al. For the International Surviving Sepsis Campaign Guidelines Committee. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. 2008 Crit Care Med 2008; 36: 296–327.CrossRefGoogle Scholar
  5. 5.
    Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002; 30: 1365–1378.PubMedCrossRefGoogle Scholar
  6. 6.
    Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003; 112: 793–799.PubMedCrossRefGoogle Scholar
  7. 7.
    Ninis N, Phillips C, Bailey L, Pollock JI, Nadel S, Britto J et al. The role of healthcare delivery on outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ 2005; 330: 1475–1482.PubMedCrossRefGoogle Scholar
  8. 8.
    Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A, et al. Meningococcal Research Group. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001; 85: 386–390.PubMedCrossRefGoogle Scholar
  9. 9.
    Kutko MC, Calarco MP, Flaherty MB, Helmrich RF, Ushay HM, Pon S et al. Mortality rates in pediatric septic shock with and without multiple organ failure. Pediatr Crit Care Med 2003; 4: 333–337.PubMedCrossRefGoogle Scholar
  10. 10.
    Karapinar B, Lin JC, Carcillo JA. ACCM guidelines use, correct antibiotic therapy, and immune suppressant withdrawal are associated with improved survival in pediatric sepsis, severe sepsis, and septic shock. Crit Care Med 2004; 32: 573.Google Scholar
  11. 11.
    Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT et al. Comparison of the three fluid solutions for resuscitation in dengue shock. N Engl J Med 2005; 353: 877–889.PubMedCrossRefGoogle Scholar
  12. 12.
    Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton C et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria:preliminary evidence of albumin benefit. Clin Infect Dis 2005; 40: 538–545.PubMedCrossRefGoogle Scholar
  13. 13.
    Nhan NT, Phuong CXT, Kneen R. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001; 32: 204–212.CrossRefGoogle Scholar
  14. 14.
    Ranjit S, Kissoon N, Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: A suggested protocol. Pediatr Crit Care Med 2005; 6: 412–419.PubMedCrossRefGoogle Scholar
  15. 15.
    Ceneviva G, Paschall JA, Maffei F. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998; 102: e19.PubMedCrossRefGoogle Scholar
  16. 16.
    De Kleijn ED, Joosten KF, Van Rijn B. Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 2002; 21: 330–336.PubMedCrossRefGoogle Scholar
  17. 17.
    Riordan FA, Thomson AP, Ratcliffe JM. Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency? Crit Care Med 1999; 27: 2257–2261.PubMedCrossRefGoogle Scholar
  18. 18.
    Min MU, Aye M. Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health 1975; 6: 573–579.PubMedGoogle Scholar
  19. 19.
    Sumarm O, Talogo W, Asrin A. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982; 69: 45–49.Google Scholar
  20. 20.
    Barton P, Garcia J, Kouatli. Hemodynamic effects of intravenous milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebocontrolled, interventional study. Chest 1996; 109: 1302–1312.PubMedCrossRefGoogle Scholar
  21. 21.
    Lindsay CA, Barton P, Lawless S et al. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. J Pediatr 1998; 132: 329–334.PubMedCrossRefGoogle Scholar
  22. 22.
    Paradsis M, Evans N, Kluckow M, Osborn D, Maclachlan AJ Pilot study of milrinone for low sysyemic blood flow in very preterm infants. J Pediatr 2006 148: 306–313.CrossRefGoogle Scholar
  23. 23.
    Irazusta JE, Pretzlaff RK, Rowin ME. Amrinone in pediatric refractory shock: An open label pharmacodynamic study. Pediatr Crit Care Med 2001; 2: 24–28.CrossRefGoogle Scholar
  24. 24.
    Sorenson GK, Ramamoorthy C, Lynn AM. Hemodynamic effects of amrinone in children after Fontan surgery. Anesth and Analg 1996; 82: 241–246CrossRefGoogle Scholar
  25. 25.
    Chang AC, Atz AM, Wernovsky G. Milrinone: systemic and pulmonary hemodynamics effects in neonates after cardiac surgery. Crit Care Med 1995; 23: 1907–1914.PubMedCrossRefGoogle Scholar
  26. 26.
    Carcillo JA, Pollack MM, Ruttimann UE. Sequential physiologic interactions in cardiogenic and septic shock. Crit Care Med 1989; 17: 6–12.CrossRefGoogle Scholar
  27. 27.
    Rivers E, Nguyen B, Havstad. Early goal directed therapy in the treatment of Severe Sepsis and Septic Shock. New Engl J Med 2001; 346: 1368–1377.CrossRefGoogle Scholar
  28. 28.
    Matejovic M, Krouzecky A, Radej J, Novak I. Successful reversal of resistant hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand 2005; 49: 127–128.PubMedCrossRefGoogle Scholar
  29. 29.
    Noto A, Giacomini M, Palandi A, Stabile L, Reali-Forster C, Iapichino G. Levosimendan in septic cardiac failure. Intensive Care Med 2005; 31: 164–165.PubMedCrossRefGoogle Scholar
  30. 30.
    Morelli A, Teboul JL, Maggiore SM, Viellard-Baron A, Rocco M, Conti G. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006; 34: 2287–2293.PubMedCrossRefGoogle Scholar
  31. 31.
    Muller K, Peters A, Zeus T, Hennersdorf M, Strauer BE. Therapy of acute decompensated heart failure with levosimendan. Med Klin 2006; 101: 119–122.Google Scholar
  32. 32.
    Namachivayam P, Crossland DS, Butt WW, Shekerdemian LS. Early experience with Levosimendan in children with ventricular dysfunction. Pediatr Crit Care 2006; 7: 445–448.CrossRefGoogle Scholar
  33. 33.
    Ringe HI, Varnholt V, Gaedicke G. Cardiac rescue with enoximone in volume and catecholamine refractory septic shock. Pediat Crit Care Med 2003; 4: 471–475.CrossRefGoogle Scholar
  34. 34.
    Kern H, Schroder T, Kaulfuss M, Martin M, Kox WJ, Spies CD. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid optimized septic shock patients. Crit Care Med 2001; 29: 1519–1525PubMedCrossRefGoogle Scholar
  35. 35.
    Holmes CL, Patel BM, Russell JA. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989–1002.PubMedCrossRefGoogle Scholar
  36. 36.
    Jackson E. Vasopressin and other agents affecting the renal conservation of water. In Hardman JG, Limbird LE ed. Goodman and Gilman’s the pharmacological basis of therapeutics. New York; McGraw Hill, 2001.Google Scholar
  37. 37.
    Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Eng J Med 2001; 345: 588–595.CrossRefGoogle Scholar
  38. 38.
    Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA. Hemodynamic and metabolic effects of low dose vasopressin infusion in vasodilatory Septic shock. Crit Care Med 2001; 29: 487–493.PubMedCrossRefGoogle Scholar
  39. 39.
    O’Brien A, Clapp L, Singer M. Terlipressin for nor epinephrine resistant shock. Lancet 2002; 359: 1209–1210.PubMedCrossRefGoogle Scholar
  40. 40.
    Yunge M, Petros A. Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 2000; 82: 388–389.PubMedCrossRefGoogle Scholar
  41. 41.
    Gregory JS, Binfiglio NF, Dasta JF. Experience with phenylephrine as a component of pharmacologic support of septic shock. Crit Care Med 1991; 19: 1340–1395.CrossRefGoogle Scholar
  42. 42.
    Redl-Wenzl EM, Armbruster C, Edelman G. The effects of norepinephrine on hemodynamics and renal function in severe septic shock. Intensive Care Med 1993; 19: 151–154.PubMedCrossRefGoogle Scholar
  43. 43.
    Meadows D, Edwards JD, Wilkins RG. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16: 663–666.PubMedCrossRefGoogle Scholar
  44. 44.
    Desjars P, Pinaud M, Potel G. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15: 134–137.PubMedCrossRefGoogle Scholar
  45. 45.
    Rosenzweig EB, Starc TJ, Chen JM. Intravenous argininevasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100: 182–186.Google Scholar
  46. 46.
    Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003; 31: 2646–2650.PubMedCrossRefGoogle Scholar
  47. 47.
    Delmas A, Leone M, Rousseau S, Albanese J, Martin C. Vasopressin and terlipressin in septic shock patients. Critical Care 2005; 9: 212–222.PubMedCrossRefGoogle Scholar
  48. 48.
    Leibovitch L, Efrati O, Vardi A, Matok I, Barzilay Z, Paret G. Intractable hypotension in septic shock: successful treatment with vasopressin in an infant. Israel Med Assoc J 2003; 5: 596–598.Google Scholar
  49. 49.
    Liedel JL, Meadow W, Nachman J, Koogler T, Kahana MD. Use of vasopressin in refractory hypotension in children with vasodilatory shock: five cases and a review of the literature. Pediatr Crit Care Med 2002; 3: 8–15.CrossRefGoogle Scholar
  50. 50.
    Vasudevan A, Lodha R, Kabra SK. Vasopressin infusion in children with catecholamine-resistant septic shock. Acta Pediatric 2005; 94: 380–383.Google Scholar
  51. 51.
    Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, Gonzalez-Alonso N, Martinon-Sanchez JM. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004; 30: 477–480.PubMedCrossRefGoogle Scholar
  52. 52.
    Matok I, Vard A, Efrati O, Rubinshtein M, Vishne T, Leibovitch L et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 2005; 23: 305–310.PubMedCrossRefGoogle Scholar
  53. 53.
    Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004; 5: 116–118.PubMedCrossRefGoogle Scholar
  54. 54.
    Peters MJ, Booth RA, Petros AJ. Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatr Crit Care Med 2004; 5: 188–189.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2008

Authors and Affiliations

  • Praveen Khilnani
    • 3
  • Satish Deopujari
    • 1
  • Joe Carcillo
    • 2
  1. 1.Department Pediatric SciencesCentral India’s Child Hospital and Research InstituteNagpurIndia
  2. 2.Pediatric Critical Care UnitPittsburgh Children HospitalPittsburghUSA
  3. 3.MAX Superspeciality HospitalNew DelhiUSA
  4. 4.B42, Panchsheel EnclaveNew Delhi-India

Personalised recommendations